Takeaways

• President Trump’s executive order significantly accelerates the long-stalled federal process to reschedule marijuana to Schedule III.
• Rescheduling could eliminate Internal Revenue Code Section 280E, fundamentally changing the tax economics of cannabis businesses.
• A move to Schedule III could unlock new federal opportunities, including potential access to trademark protections previously unavailable to cannabis operators.

On December 18, 2025, President Trump signed an executive order to fast-track the reclassification of marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). Schedule I is the most restrictive classification under the CSA and is reserved for drugs with no currently accepted medical use and a high potential for abuse. Other Schedule I drugs include heroin, LSD, and ecstasy. By contrast, Schedule III drugs are those with a moderate to low potential for physical and psychological dependence, such as Tylenol with codeine. The gravity of this decision and its impact on the cannabis industry cannot be overstated.Continue Reading President Trump Signs Executive Order To Reschedule Marijuana To Schedule III: Quick Takeaways for Cannabis Operators